We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




AI-Powered Smart PCR System to Revolutionize Clinical Diagnostics

By LabMedica International staff writers
Posted on 23 Oct 2024
Print article
Image: Researcher Caitlin McDonald who led the study presented the PCR research at the International Society of Forensic Genetics conference (Photo courtesy of Flinders University)
Image: Researcher Caitlin McDonald who led the study presented the PCR research at the International Society of Forensic Genetics conference (Photo courtesy of Flinders University)

Polymerase chain reaction (PCR) is a widely used laboratory technique for amplifying or copying small segments of genetic material, applicable in areas such as DNA fingerprinting, diagnosing genetic disorders, and detecting pathogens like COVID-19. From medical diagnostics to forensic testing and national security, PCR DNA profiling has transformed high-throughput sampling in the 21st century, yet little has changed since its inception in the 1980s. Traditional DNA amplification requires that all parameters be established before the process begins, overlooking the variations that may exist between samples and conditions. Even minor enhancements in PCR performance could significantly affect the hundreds of thousands of DNA samples amplified each year, especially when dealing with degraded samples. Researchers have now made advancements in critical DNA testing by incorporating machine learning into DNA profiling.

The new research by experts at Flinders University (Bedford Park, SA, Australia) revealed substantial improvements in both the quality of DNA profiling and the efficiency of PCR cycling conditions through the application of artificial intelligence (AI) techniques. In their study, the researchers employed machine learning to develop new "smart PCR" systems, focusing on large-scale potential modifications and quicker cycling conditions for faster and more accurate results. Their findings, published in an article in Genes, demonstrated how to set up a system that enables a PCR process to provide real-time feedback, allowing a machine-learning algorithm to make instantaneous adjustments to PCR conditions.

By leveraging advancements in machine learning and sensor technology, the researchers have transformed the PCR process from a one-size-fits-all approach to a tailored and optimized experience, achieving higher quality and greater quantities of DNA in less time than previously possible. According to the researchers, if harnessed effectively, AI and machine learning could significantly enhance the sensitivity of PCR testing. With continued research, these AI-ML methodologies hold promise for improving the quality of trace DNA samples.

“Our system has the potential to overcome challenges that have hindered forensic scientists for decades, especially with trace, inhibited, and degraded samples,” said College of Science and Engineering PhD candidate Caitlin McDonald, who led the study. “By intelligently optimizing PCR for a wide variety of sample types, it can dramatically enhance amplification success, delivering more reliable results in even the most complex cases.”

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Blood Gas and Chemistry Analysis System
Edan i500

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.